Risks and Benefits of HRT Versus ERT in Order to Separate HRT from ERT
Studies that randomized peri-menopausal and menopausal women to either HRT or ERT versus placebo and one study that included
similar women followed up prospectively for the incidence of the development of Alzheimer’s Dementia (AD).
Results: The significant risks of HRT included CHD, stroke and pulmonary embolism. The risk of breast cancer only really existed after long term
follow-up [(annualized incidence, 0.45% vs 0.36%; Hazard Ratio (HR) 1.28)]. The significant risks of ERT only included strokes. There was a lower
risk of breast cancer in the long term [HR 0.77, 95% CI 0.62–0.95; p=0.02].
Conclusions: In women with a uterus, where HRT instead of ERT is mandated, the oral progestogen of HRT can be replaced by intrauterine
device loaded with a Progestogen. Similarly, the oral Estrogen of HRT and ERT can be replaced by Estrogen sources like the patch, gel or implants
that bypass the liver and bypass potential problems like strokes and pulmonary embolism.
https://www.stephypublishers.com/pwhcij/pdf/PWHCIJ.MS.ID.000511.pdf
Comments
Post a Comment